Accolade (ACCD) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.28 per share a year ago. These figures are ...

One stock that might be an intriguing choice for investors right now is Accolade, Inc. ACCD. This is because this security in the Technology Services space is seeing solid earnings estimate revision ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Accolade Inc (NASDAQ:ACCD) stands against the ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Accolade, Inc. (NASDAQ:ACCD) stands against the other smid-cap ...

I continue to recommend a buy rating with a projected 20% growth in FY25. Recent results show that Accolade beat consensus estimates for revenue and EBITDA, and management expects 20% revenue growth ...

ACCD's Q3 FY 2024 top line and non-GAAP adjusted EBITDA loss came in better than the Wall Street analysts had anticipated. Accolade also revised its FY 2024 revenue outlook upwards, and shared its ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Accolade, Inc. (NASDAQ: ACCD) to Transcarent for $7.03 per share in cash is fair to ...